Skip to content

Effect of iron replacement therapy in patients with chronic heart failure and iron deficiency anemia

Evaluation of the effect of iron replacement therapy on symptom and quality of life in patients with chronic heart failure and iron deficiency who referred to Isfahan's Shariarti hospital in 1392-93

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013112813828N5
Enrollment
46
Registered
2014-03-18
Start date
2014-03-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure. Heart failure

Interventions

Before starting intervention hemoglobin level,serum iron,Toral iron binding capacity,transferrin saturation and ferritin will be measured.also patient's quality of life and 6 minute walk test will be
Treatment - Drugs

Sponsors

Islamic Azad University, Najafabad Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria:patient's consent;patients with stable chronic heart failure;Iron deficiency anemia;Age between 30 and 75 years old exclusion criteria:No consent to participate in study;patient with unstable heart failure;Patient with hemoglobinopathy;Patient with B12 and follic acid deficiency;Pregnancy;Age less than30 or more than75 years old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
6 Minute Walk Test. Timepoint: Before intervention and also afte iron deficiency anemia treatmen. Method of measurement: This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes.;Quality Of Llife. Timepoint: Before intervention and also after iron deficiency anemia treatment. Method of measurement: Quality Of Llife Questionnaire.;New York Heart Association Functional Classification. Timepoint: Before intervention and also afte iron deficiency anemia treatmen. Method of measurement: patient's words.

Secondary

MeasureTime frame
Serum creatinine. Timepoint: before intervention and after iron deficiency anemia treatment. Method of measurement: jaffe.;Glomerular filtration rate. Timepoint: before intervention and after iron deficiency anemia treatment. Method of measurement: (140-age)*mass(in kilogram)*(0.85 if female/72*serum creatinine(in mg/dl).

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026